Current Pharmacology Reports
Last updated ISSN 2198-641X
Current Pharmacology Reports is published by Springer Science+Business Media in biochemistry, genetics and molecular biology. It is a subscription journal. The article processing charge is $4,790.
Is your paper a fit?
The surest way to know is to compare your own abstract against what this journal has actually been publishing, rather than against its aims-and-scope page. Paste your abstract and Journal Hunt will tell you how close Current Pharmacology Reports is — and show you journals like it.
What it publishes
Recent work in Current Pharmacology Reports concentrates on these topics, taken from its published record rather than from its own description:
- Epigenetics and DNA Methylation
- Genomics, phytochemicals, and oxidative stress
- Phytochemicals and Antioxidant Activities
- Computational Drug Discovery Methods
- Pharmacogenetics and Drug Metabolism
- Natural Antidiabetic Agents Studies
- SARS-CoV-2 and COVID-19 Research
- RNA modifications and cancer
- COVID-19 Clinical Research Studies
- MicroRNA in disease regulation
Key facts
| Publisher | Springer Science+Business Media |
|---|---|
| ISSN | 2198-641X |
| Subject area | Biochemistry, Genetics and Molecular Biology |
| Access | Subscription |
| Article processing charge | $4,790 |
| Indexed in | Scopus |
| Articles published | 469 |
| Publishing since | 2015 |
| Journal website | www.springer.com/journal/40495 |
Facts come from OpenAlex, DOAJ and Wikidata and may lag the journal’s own pages. Check the publisher’s site before submitting. Indexing shown here is what is recorded, not a complete picture — about a third of journals have no indexing recorded anywhere we can read, so “not recorded” does not mean a journal is absent from Scopus or Web of Science.
Journals like Current Pharmacology Reports
Other established journals in biochemistry, genetics and molecular biology, if this one is not the right home for your paper: